Healx
✓ Verified
Healthcare AI
Rare disease drug discovery and drug repurposing
Series C
Healx is a Cambridge, UK-based AI-powered biotech company focused on rare disease drug discovery and repurposing. It uses an AI platform to identify novel drug-disease connections, prioritize therapeutic opportunities, and advance candidates through preclinical and clinical development, including rare and pediatric oncology programs.
Company Details
- Website
- healx.ai
- Headquarters
- Cambridge, Cambridgeshire, United Kingdom
- Founded
- 2014
- Funding
- $114.9M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring